Clinical contributors to cerebral white matter integrity in HIV-infected individuals

Journal of NeuroVirology

Volumn 17, Issue 5, 2011, Pages 477-486

  Gongvatana, Assawin ^a   Cohen, Ronald A ^a   Correia, Stephen ^a   Devlin, Kathryn N ^a   Miles, Jadrian ^b   Kang, Hakmook ^c   Ombao, Hernando ^d   Navia, Bradford ^e   Laidlaw, David H ^b   Tashima, Karen T ^a  

^a BROWN UNIVERSITY   (United States)

^b Brown Univerity   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral treatment; Cerebral white matter; Diffusion tensor imaging; Hepatitis c infection; HIV infection; Neuroimaging

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGED; AGING; ARTICLE; BRAIN DYSFUNCTION; BRAIN INJURY; BRAIN REGION; CD4 LYMPHOCYTE COUNT; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; FEMALE; FRACTIONAL ANISOTROPY; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE; WHITE MATTER;

ADULT; AGED; ANISOTROPY; ANTI-RETROVIRAL AGENTS; CEREBRUM; COINFECTION; CROSS-SECTIONAL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; LEUKOENCEPHALOPATHIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; VIRAL LOAD; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 84856189724     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0055-0     Document Type: Article

References (51)

1. Alexander DC, Pierpaoli C, Basser PJ, Gee JC (2001) Spatial transformations of diffusion tensor magnetic resonance images. IEEE Trans Med Imaging 20(11):1131-1139. doi:10.1109/42.963816 (Pubitemid 33106067)
2. Anthony IC, Bell JE (2008) The neuropathology of HIV/AIDS. Int Rev Psychiatr (Abingdon, England) 20(1):15-24. doi:10.1080/09540260701862037 (Pubitemid 351196199)
3. Basser PJ, Jones DK (2002) Diffusion-tensor MRI: theory, experimental design and data analysis-a technical review. NMR Biomed 15(7-8):456-467. doi:10.1002/nbm.783 (Pubitemid 36054509)
4. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57(1):289-300
5. Brew BJ (2004) Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1):S75-S78 (Pubitemid 38365909)
6. Chen Y, An H, Zhu H, Stone T, Smith JK, Hall C, Bullitt E et al (2009) White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuro-Image 47(4):1154-1162. doi:10.1016/j. neuroimage.2009.04.030
7. Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I et al (2005) Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 64(8):1343-1347. doi:10.1212/01. WNL.0000158328.26897.0D (Pubitemid 40570498)
8. Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, Tamburrini E et al (2011) Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology 76(16):1403-1409. doi:10.1212/WNL.0b013e31821670fb
9. Clifford DB, Evans SR, Yang Y, Gulick RM (2005) The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS 19(Suppl 3):S64-S71 (Pubitemid 41682171)
10. Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R et al (2010a) Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol 16(1):25-32. doi:10.3109/13550280903552420
11. Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R et al (2010b) Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J Neurovirol. doi:10.3109/13550284.2010.520817
12. Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29(3):162-173 (Pubitemid 26266657)
13. Cysique LA, Maruff P, Brew BJ (2004) Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre-and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 10(6):350-357 (Pubitemid 40109622)
14. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31(3):968-980. doi:10.1016/j.neuroimage.2006.01.021 (Pubitemid 44183792)
15. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I et al (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group HIV. Neurobehav Res Cent Brain Pathol 9(2):209-217 (Pubitemid 29157710)
16. Filippi CG, Ulug AM, Ryan E, Ferrando SJ, van Gorp W (2001) Diffusion tensor imaging of patients with HIV and normalappearing white matter on MR images of the brain. AJNR Am J Neuroradiol 22(2):277-283 (Pubitemid 32163456)
17. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn BT, Dale AM (2004) Sequence-independent segmentation of magnetic resonance images. NeuroImage 23(Suppl 1):S69-S84. doi:10.1016/j.neuroimage.2004.07.016 (Pubitemid 39429376)
18. Forton DM, Hamilton G, Allsop JM, Grover VP, Wesnes K, O'Sullivan C, Thomas HC et al (2008) Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol 49(3):316-322. doi:10.1016/j. jhep. 2008.03.022
19. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, Tavolato B et al (1997) Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 42(1):34-40. doi:10.1002/ana.410420108 (Pubitemid 27304778)
20. Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J et al (2009) White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol 15(2):187-195. doi:10.1080/13550280902769756
21. Gray F, Lescs MC (1993) HIV-related demyelinating disease. Eur j Med 2(2):89-96 (Pubitemid 23082973)
22. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA et al (1995) The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc: JINS 1(3):231-251
23. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23):2087-2096. doi:10.1212/WNL.0b013e318200d727
24. Hilsabeck RC, Castellon SA, Hinkin CH (2005) Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clin Infect Dis 41(Suppl 1):S38-S44. doi:10.1086/429494 (Pubitemid 40863723)
25. Hinkin CH, Castellon SA, Levine AJ, Barclay TR, Singer EJ (2008) Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis 27(2):11-17
26. Jernigan TL, Archibald S, Hesselink JR, Atkinson JH, Velin RA, McCutchan JA, Chandler J et al (1993) Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol 50(3):250-255 (Pubitemid 23069608)
27. Kirk JB, Goetz MB (2009) Human immunodeficiency virus in an aging population, a complication of success. J Am Geriatr Soc 57(11):2129-2138. doi:10.1111/j.1532-5415.2009.02494.x
28. Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M, Nikolopoulou GB et al (2002) Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 76(19):10064-10068 (Pubitemid 35006549)
29. Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R et al (2007) Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 196(3):361-370. doi:10.1086/519285 (Pubitemid 47093886)
30. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB et al (2008) Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65(1):65-70. doi:10.1001/archneurol.2007.31
31. Maggi F, Giorgi M, Fornai C, Morrica A, Vatteroni ML, Pistello M, Siciliano G et al (1999) Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol 5(3):319-323 (Pubitemid 29329107)
32. Martin-Thormeyer EM, Paul RH (2009) Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features. Neuropsychol Rev 19(2):215-231. doi:10.1007/s11065- 009-9101-6
33. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL et al (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42(6):963-972. doi:10.1002/ana. 410420618 (Pubitemid 28008427)
34. McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ (2005) Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 41(4):801-808. doi:10.1002/hep. 20635 (Pubitemid 40462942)
35. Pfefferbaum A, Rosenbloom MJ, Rohlfing T, Kemper CA, Deresinski S, Sullivan EV (2009) Frontostriatal fiber bundle compromise in HIV infection without dementia. AIDS 23(15):1977-1985. doi:10.1097/QAD.0b013e32832e77fe
36. Pomara N, Crandall DT, Choi SJ, Johnson G, Lim KO (2001) White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res 106(1):15-24 (Pubitemid 32174865)
37. Ragin AB, Wu Y, Storey P, Cohen BA, Edelman RR, Epstein LG (2005) Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol 11(3):292-298. doi:10.1080/ 13550280590953799 (Pubitemid 41122417)
38. Salat DH, Greve DN, Pacheco JL, Quinn BT, Helmer KG, Buckner RL, Fischl B (2009) Regional white matter volume differences in nondemented aging and Alzheimer's disease. NeuroImage 44(4):1247-1258. doi:10.1016/j.neuroimage.2008. 10.030
39. Shiramizu B, Williams AE, Shikuma C, Valcour V (2009) Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders. J Neuropsychiatry Clin Neurosci 21(1):68-74. doi:10.1176/appi. neuropsych.21.1.68
40. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR et al (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23(Suppl 1):S208-S219. doi:10.1016/j. neuroimage.2004.07.051 (Pubitemid 39421720)
41. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE et al (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 31(4):1487-1505. doi:10.1016/j.neuroimage. 2006.02.024
42. Stebbins GT, Smith CA, Bartt RE, Kessler HA, Adeyemi OM, Martin E, Cox JL et al (2007) HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study. J Acquir Immune Defic Syndr 46(5):564-573 (Pubitemid 350191049)
43. Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, McCutchan JA et al (1998) Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol 55(2):161-168
44. Sullivan EV, Pfefferbaum A (2006) Diffusion tensor imaging and aging. Neurosci Biobehav Rev 30(6):749-761. doi:10.1016/j. neubiorev. 2006.06.002 (Pubitemid 44292284)
45. Thurnher MM, Castillo M, Stadler A, Rieger A, Schmid B, Sundgren PC (2005) Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients. AJNR Am J Neuroradiol 26(9):2275-2281
46. Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P et al (2004) Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63(5):822-827 (Pubitemid 39297641)
47. Verucchi G, Calza L, Manfredi R, Chiodo F (2004) Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 32(1):33-46. doi:10.1007/s15010-004-3063-7 (Pubitemid 38210511)
48. von Giesen H-J, Heintges T, Abbasi-Boroudjeni N, Kücükkö ylü S, Köller H, Haslinger BA, Oette M et al (2004) Psychomotor slowing in hepatitis C and HIV infection. J Acquir Immune Defic Syndr 35(2):131-137 (Pubitemid 38133735)
49. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen JC, Ahl B et al (2004) Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41(5):845-851. doi:10.1016/j. jhep. 2004.07.022 (Pubitemid 39434316)
50. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH et al (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26(6):759-778. doi:10.1080/ 13803390490509565 (Pubitemid 39362659)
51. Wu Y, Storey P, Cohen BA, Epstein LG, Edelman RR, Ragin AB (2006) Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol 27(3):656-660 (Pubitemid 44897794)